Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

This is the first of a two-case series. This case presents the situation faced by Ofra Sherman, the General Manager of Wellcome Israel, a subsidiary of Wellcome PLC and represented in Israel by Promedico, during the merger of the pharmaceutical companies Glaxo and Wellcome. Sherman faced the difficulties of managing her team during the transition and the anticipated loss of the organisation's independence. These problems were exacerbated by the division's uncertain relationship to its parent company. The case provides opportunities for understanding ambiguous change situations and their implications for career; looking at mergers and takeovers from the point of view of middle managers; and considering externally-imposed changes to successful teams.
Location:
Industry:
Size:
15 employees in division
Other setting(s):
1995

About

Abstract

This is the first of a two-case series. This case presents the situation faced by Ofra Sherman, the General Manager of Wellcome Israel, a subsidiary of Wellcome PLC and represented in Israel by Promedico, during the merger of the pharmaceutical companies Glaxo and Wellcome. Sherman faced the difficulties of managing her team during the transition and the anticipated loss of the organisation's independence. These problems were exacerbated by the division's uncertain relationship to its parent company. The case provides opportunities for understanding ambiguous change situations and their implications for career; looking at mergers and takeovers from the point of view of middle managers; and considering externally-imposed changes to successful teams.

Settings

Location:
Industry:
Size:
15 employees in division
Other setting(s):
1995

Related